Abstract:Protein misfolding and its aggregation known as amyloid aggregates (Aβ) are one of the major causes of more than 20 diseases such as Parkinson, Alzheimer, type 2 diabetes, etc. The process of Aβ formation involves energy-driven oligomerization of Aβ monomers, leading to polymerization and eventual aggregation into fibrils. Aβ fibril contains multilevel chirality coming from its amino acid residue and arrangement of folded polypeptide chains thus a chirality-driven approach can be utilized for the detection and inhibition of Aβ fibril. In this regard chiral nanomaterials have recently opened new possibilities for its various biomedical applications, thanks to their stereoselective interaction with biological systems. Leveraging this chirality-driven approach with chiral nanomaterials against protein-aggregate diseases could yield promising results, particularly in the early detection of Aβ forms and inhibition of Aβ aggregates through specific and strong "chiral-chiral interaction." Despite the advantages, the development of advanced theranostic systems using chiral nanomaterials against protein-aggregate diseases has received limited attention so far because of very limited chiral nanomaterials formulations and lack of information of their chiroptical behavior. This review aims to present the current status of chiral nanomaterials explored for detecting and inhibiting Aβ forms. The article covers the origin of chirality in amyloids fibril and nanomaterials and different chiral detection methods furthermore different chiral nanosystems such as chiral plasmonic nanomaterials, chiral carbon-based nanomaterials, and chiral nanosurfaces which were used so far for different therapeutic applications against protein aggregated diseases were discussed in detail. The findings from this review may pave the way for novel approaches using chiral nanomaterials to combat diseases resulting from protein misfolding and further can be extended to other disease forms.

Chiral bias of amyloid fibrils revealed by the twisted conformation of Thioflavin T: An induced circular dichroism/DFT study

Induced and Inversed Circularly Polarized Luminescence of Achiral Thioflavin T Assembled on Peptide Fibril.

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Chiral effect on Aβ fibrillation from molecular-scale to nanoscale

Effect of Ionic Strength on Thioflavin-T Affinity to Amyloid Fibrils and Its Fluorescence Intensity

Amyloid β (1–42) Folding Multiplicity and Single-Molecule Binding Behavior Studied with STM

Imaging linear birefringence and dichroism in cerebral amyloid pathologies

In Silico Study of Recognition Between Aβ40 and Aβ40 Fibril Surfaces: an N-Terminal Helical Recognition Motif and Its Implications for Inhibitor Design

Monitoring Amyloid Aggregation Via a Twisted Intramolecular Charge Transfer (Tict)-Based Fluorescent Sensor Array

Monitoring Amyloid Aggregation via Twisted Intramolecular Charge Transfer (TICT)-Based Fluorescent Sensor Array

Chiral nanomaterials-based approaches for diagnosis and treatment of protein aggregated neurodiseases: current status and future opportunities

Insulin Amyloid Fibrillation Studied by Terahertz Spectroscopy and Other Biophysical Methods

Interrogating Amyloid Aggregation with Aggregation-Induced Emission Fluorescence Probes.

Detection of Strongly Bound Thioflavin T Species in Amyloid Fibrils by Ligand-Detected 1H NMR

Effect of the fluorescent probes ThT and ANS on the mature amyloid fibrils

Cationic molecular probes based on aggregation-induced emission for fluorescent sensing and super-resolution imaging of insulin fibrosis

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin

Chiral Effect at Protein/Graphene Interface: A Bioinspired Perspective to Understand Amyloid Formation

Curved Nanointerface Controls the Chiral Effect on Peptide Fibrillation